ARCHIVES

FDA Approives Lilly’s Alimta For 1st-Line Metastatic NSCLC

This article is from The Cancer Letter archive.

Vol. 31 No. 9 | September 26, 2008

Download PDF Visit The Full Archive

Related Articles

NCI Grants Funding: New Funds Moved Into R01s, other Extramural Priorities

December 12, 1997

DePinho Explains Tenure Decision,Professors Dispute Key Details

May 30, 2014

Senate “Pleased” About Reductions In Incidence And Mortality

October 8, 1999

Columbia Receives $1 Million ACS Grants

May 3, 1985

Non-Profit Spent $1.3 Million On Consultants.

March 28, 2008

NIH Slow To Implement Equality In Studies, GAO Says, But Waxman Assures Reauthorization

June 22, 1990